Post-pandemic Era-Global Ophthalmic Therapeutics/Drug Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Ophthalmic Therapeutics/Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Ophthalmic Therapeutics/Drug Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Ophthalmic Therapeutics/Drug Market?
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
...
Major Type of Ophthalmic Therapeutics/Drug Covered in XYZResearch report
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Application Segments Covered in XYZResearch Market
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Ophthalmic Therapeutics/Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Anti-allergy -Product Introduction and Major Manufacturers
1.1.2 Anti-VEGF Agents -Product Introduction and Major Manufacturers
1.1.3 Anti-inflammatory -Product Introduction and Major Manufacturers
1.1.4 Anti-glaucoma -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.1.1 China Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.2.1 EU Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.3.1 USA Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.4.1 Japan Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.5.1 India Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.7.1 South America Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Ophthalmic Therapeutics/Drug Status and Prospect (2015-2026)
2.8.1 Ophthalmic Therapeutics/Drug Market Size and Growth Rate (2015-2026)
2.8.2 Ophthalmic Therapeutics/Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Ophthalmic Therapeutics/Drug Market Assessment by Segment
3.1 Global Ophthalmic Therapeutics/Drug Capacity and Growth Rate
3.2 Global Ophthalmic Therapeutics/Drug Sales by Type
3.3 Global Ophthalmic Therapeutics/Drug Sales Revenue by Type
3.4 Global Ophthalmic Therapeutics/Drug Consumption by Application
4 Global Ophthalmic Therapeutics/Drug Market Assessment by Regions
4.1 Global Ophthalmic Therapeutics/Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Ophthalmic Therapeutics/Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Ophthalmic Therapeutics/Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Ophthalmic Therapeutics/Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Ophthalmic Therapeutics/Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Ophthalmic Therapeutics/Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Ophthalmic Therapeutics/Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Ophthalmic Therapeutics/Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Ophthalmic Therapeutics/Drug Competitive Analysis
7.1 Alcon
7.1.1 Alcon Company Profiles
7.1.2 Alcon Product Introduction
7.1.3 Alcon Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Johnson and Johnson Vision Care, Inc.
7.2.1 Johnson and Johnson Vision Care, Inc. Company Profiles
7.2.2 Johnson and Johnson Vision Care, Inc. Product Introduction
7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bausch & Lomb Incorporated
7.3.1 Bausch & Lomb Incorporated Company Profiles
7.3.2 Bausch & Lomb Incorporated Product Introduction
7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Novartis AG
7.4.1 Novartis AG Company Profiles
7.4.2 Novartis AG Product Introduction
7.4.3 Novartis AG Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Merck Sharp & Dohme Corp.
7.5.1 Merck Sharp & Dohme Corp. Company Profiles
7.5.2 Merck Sharp & Dohme Corp. Product Introduction
7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Regeneron Pharmaceuticals Inc.
7.6.1 Regeneron Pharmaceuticals Inc. Company Profiles
7.6.2 Regeneron Pharmaceuticals Inc. Product Introduction
7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Allergan
7.7.1 Allergan Company Profiles
7.7.2 Allergan Product Introduction
7.7.3 Allergan Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Profiles
7.8.2 Pfizer Inc. Product Introduction
7.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Valeant
7.9.1 Valeant Company Profiles
7.9.2 Valeant Product Introduction
7.9.3 Valeant Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Bayer AG
7.10.1 Bayer AG Company Profiles
7.10.2 Bayer AG Product Introduction
7.10.3 Bayer AG Ophthalmic Therapeutics/Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Santen Pharmaceuticals Co. Ltd
7.12 Genentech, Inc.
8 Conclusion
List of Figure
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Ophthalmic Therapeutics/Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Ophthalmic Therapeutics/Drug Sales (K Unit) by Type (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Ophthalmic Therapeutics/Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Ophthalmic Therapeutics/Drug Sales (K Unit) by Application (2015-2026)
Figure China Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Ophthalmic Therapeutics/Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Ophthalmic Therapeutics/Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Ophthalmic Therapeutics/Drug Sales (Unit) by Type (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Ophthalmic Therapeutics/Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Ophthalmic Therapeutics/Drug Consumption (Unit) by Application (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Ophthalmic Therapeutics/Drug Production (K Unite) by Regions (2015-2020)
Table Global Ophthalmic Therapeutics/Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Production Share by Regions (2019-2020)
Table Global Ophthalmic Therapeutics/Drug Sales (K Unite) by Regions (2015-2020)
Table Global Ophthalmic Therapeutics/Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales Share by Regions (2019-2020)
Table Global Ophthalmic Therapeutics/Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Ophthalmic Therapeutics/Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Ophthalmic Therapeutics/Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Ophthalmic Therapeutics/Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Ophthalmic Therapeutics/Drug
Figure Cost Structure of Ophthalmic Therapeutics/Drug in 2020
Table Global Ophthalmic Therapeutics/Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Ophthalmic Therapeutics/Drug Capacity Share of Manufacturers (2019-2020)
Table Global Ophthalmic Therapeutics/Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Ophthalmic Therapeutics/Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Ophthalmic Therapeutics/Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Ophthalmic Therapeutics/Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Ophthalmic Therapeutics/Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ??Alcon Profiles
Table ??Alcon Ophthalmic Therapeutics/Drug Product Introduction
Table ??Alcon Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ??Alcon SWOT Analysis
Table ????Johnson and Johnson Vision Care, Inc. Profiles
Table ????Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Introduction
Table ????Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Johnson and Johnson Vision Care, Inc. SWOT Analysis
Table ????Bausch & Lomb Incorporated Profiles
Table ????Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Introduction
Table ????Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Bausch & Lomb Incorporated SWOT Analysis
Table ????Novartis AG Profiles
Table ????Novartis AG Ophthalmic Therapeutics/Drug Product Introduction
Table ????Novartis AG Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Novartis AG SWOT Analysis
Table ????Merck Sharp & Dohme Corp. Profiles
Table ????Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Introduction
Table ????Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Merck Sharp & Dohme Corp. SWOT Analysis
Table ????Regeneron Pharmaceuticals Inc. Profiles
Table ????Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Introduction
Table ????Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Regeneron Pharmaceuticals Inc. SWOT Analysis
Table ????Allergan Profiles
Table ????Allergan Ophthalmic Therapeutics/Drug Product Introduction
Table ????Allergan Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Allergan SWOT Analysis
Table ????Pfizer Inc. Profiles
Table ????Pfizer Inc. Ophthalmic Therapeutics/Drug Product Introduction
Table ????Pfizer Inc. Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pfizer Inc. SWOT Analysis
Table ????Valeant Profiles
Table ????Valeant Ophthalmic Therapeutics/Drug Product Introduction
Table ????Valeant Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Valeant SWOT Analysis
Table ????Bayer AG Profiles
Table ????Bayer AG Ophthalmic Therapeutics/Drug Product Introduction
Table ????Bayer AG Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Bayer AG SWOT Analysis
Table ????Santen Pharmaceuticals Co. Ltd Profiles
Table ????Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Introduction
Table ????Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Santen Pharmaceuticals Co. Ltd SWOT Analysis
Table ????Genentech, Inc. Profiles
Table ????Genentech, Inc. Ophthalmic Therapeutics/Drug Product Introduction
Table ????Genentech, Inc. Ophthalmic Therapeutics/Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Genentech, Inc. SWOT Analysis
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices